Erratum to: Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension

類似資料

• Alendronate sodium/vitamin D(3) combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
  著者:: Zhang, Z. L., 等
  出版事項: (2015)
• ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
  著者:: Bone, Henry G, 等
  出版事項: (2018)
• Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
  著者:: Hiligsmann, M., 等
  出版事項: (2021)
• Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis
  著者:: Yoo, Jun-Il, 等
  出版事項: (2017)
• Alendronate improves QOL of postmenopausal women with osteoporosis
  著者:: Kawate, Hisaya, 等
  出版事項: (2010)